Sero-Prevalence of Sarscov-2 Specific Antibodies (Coronavirus Disease 19 Pakistan)

Authors

  • Mujahid Hussain M.Phil. Health Economics Pakistan Institute of Development Economics (PIDE Islamabad)
  • Dr. Sameen Abbas PhD clinical pharmacy Department of pharmacy, Quaid e Azam University Islamabad
  • Dr. Sara Shahid Department of Pharmacy, Lahore Pharmacy College Lahore Medical & Dental College UHS, Lahore, Pakistan
  • Dr. Anosh Sana M.Phil pharmacy practice Department of pharmacy, Quaid e Azam University Islamabad
  • Muhammad sultan M.Phil. Health Economics Pakistan Institute of Development Economics (PIDE Islamabad)

DOI:

https://doi.org/10.51699/ijhsms.v1i1.17

Keywords:

COVID-19, SERO-prevalence, SARS CoV-2

Abstract

Approaching the eve of the year 2019 in the province of the Hubei China a cluster of pneumonia was detected and the world was hit by the another epidemic which was then called ‘Novel coronavirus outbreak’ referring to a cause by a virus of unknown origin, after research done by scientists in China the disease was known to cause by a Virus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), later on 12 March 2020 the disease caused by said virus was named as Corona Virus Disease 19(COVID-19) . The aim of this study is to determine the SERO-prevalence of COVID-in the residents of Pakistan

Methodology: The study will be a quantitative descriptive cross-sectional population-based method is used in this study.

Results: This SERO--prevalence study revealed thet 9.3 % of the population was SERO--positive for COVID-19 and 36 percent were asymptomatic persons which is very high. The research also indicated that males and middle- and older-aged people were most impacted. Also, the study resulted in that the prevalence of COVID-19 in contacts of a confirmed positive case was 18 percent

Conclusion: The conclusion of this study implies to Pakistan’s small province rural setting still it can be served as useful insights for guiding public health planning, practices and for installation of policies to decrease COVID-19 related human and economic losses. It is very important to mention that further research and studies are very much required in this purpose to find the true disease burden of COVID-19 as every study or research adds new information to the past experiences and also due to the nature of this pandemic as it comes in high and low phases during the whole years.

Downloads

Download data is not yet available.

Downloads

Published

2022-08-03

How to Cite

Hussain, M. ., Abbas, D. S. ., Shahid, D. S. ., Sana, D. A. ., & sultan, M. . (2022). Sero-Prevalence of Sarscov-2 Specific Antibodies (Coronavirus Disease 19 Pakistan). INTERNATIONAL JOURNAL OF HEALTH SYSTEMS AND MEDICAL SCIENCES, 1(1), 10–23. https://doi.org/10.51699/ijhsms.v1i1.17

Issue

Section

Articles